P716 Exclusive Enteral Nutrition refurbishes beneficial gut microbiota in patients with Acute Severe Ulcerative Colitis. (21st January 2022)
- Record Type:
- Journal Article
- Title:
- P716 Exclusive Enteral Nutrition refurbishes beneficial gut microbiota in patients with Acute Severe Ulcerative Colitis. (21st January 2022)
- Main Title:
- P716 Exclusive Enteral Nutrition refurbishes beneficial gut microbiota in patients with Acute Severe Ulcerative Colitis
- Authors:
- Bajaj, A
Markandey, M
Sahu, P
Vuyyuru, S K
Kante, B
Kumar, P
Singh, N
Gupta, A
Singh, M
Verma, M
Makharia, G
Kedia, S
Ahuja, V - Abstract:
- Abstract: Background: Exclusive enteral nutrition (EEN) acts as an adjunctive therapy to intravenous corticosteroids in patients with ASUC. Recently reported by Sahu et.al., patients with ASUC undergoing EEN showed reduced corticosteroid failure rates compared with standard-of-care (SOC) group 1 . While the mechanism of action of EEN is unclear, EEN is known to cause marked alterations in the gut microbiome. The present study extending the findings of Sahu et.al., aims to decipher the compositional changes in gut microbiome accompanying the EEN-augmented steroid responsiveness Methods: In an open-label RCT, patients with ASUC were randomized 1:1 to EEN and SOC groups. Patients on EEN received a semi-elemental formula for 7 days along with SOC. The primary outcome was steroid failure, defined by the need for salvage medical intervention. Faecal microbial analysis was performed on day-0 and day-7 by 16S-rRNA gene sequencing. Processing of raw reads, ASV tables, diversity, and core microbiome analysis was done using QIIME2-2021.4. Differential abundance analysis (DAA) was performed using Deseq2. Results: The α and β diversity indices showed deviation neither in EEN nor in SOC groups. EEN caused a shift in core microbiota of patients with ASUC, adding Streptococcus and Faecalibacterium prausnitzii, while SOC could not change the core microbiota. DAA on the pre- and post-treatment samples showed that EEN resulted in diminished Ruminococcus gnavus, Escherichia sp., BifidobacteriumAbstract: Background: Exclusive enteral nutrition (EEN) acts as an adjunctive therapy to intravenous corticosteroids in patients with ASUC. Recently reported by Sahu et.al., patients with ASUC undergoing EEN showed reduced corticosteroid failure rates compared with standard-of-care (SOC) group 1 . While the mechanism of action of EEN is unclear, EEN is known to cause marked alterations in the gut microbiome. The present study extending the findings of Sahu et.al., aims to decipher the compositional changes in gut microbiome accompanying the EEN-augmented steroid responsiveness Methods: In an open-label RCT, patients with ASUC were randomized 1:1 to EEN and SOC groups. Patients on EEN received a semi-elemental formula for 7 days along with SOC. The primary outcome was steroid failure, defined by the need for salvage medical intervention. Faecal microbial analysis was performed on day-0 and day-7 by 16S-rRNA gene sequencing. Processing of raw reads, ASV tables, diversity, and core microbiome analysis was done using QIIME2-2021.4. Differential abundance analysis (DAA) was performed using Deseq2. Results: The α and β diversity indices showed deviation neither in EEN nor in SOC groups. EEN caused a shift in core microbiota of patients with ASUC, adding Streptococcus and Faecalibacterium prausnitzii, while SOC could not change the core microbiota. DAA on the pre- and post-treatment samples showed that EEN resulted in diminished Ruminococcus gnavus, Escherichia sp., Bifidobacterium longum and Enterococcus sp., while the SOC led to reduction in beneficial F . prausnitzii and enhanced Escherichia . DAA between steroid responders and steroid non-responders in the EEN group, showed significant enhancement of Veillonella, Ligilactobacillus, Limosilactobacillus, Gamella, Enterococcus and Eggerthella in the SR group, while Schaalia, R.gnavus, Lactobacillus, Bifidobacterium, Haemophilus were elevated in SNR group. Conclusion: ASUC accompanies gut dysbiosis. EEN refurbishes certain beneficial gut microbial genera, which may account for its augmentation of the steroid responsiveness in patients with ASUC. Reference: 1. Sahu P, Kedia S, Vuyyuru SK, Bajaj A, Markandey M, Singh N, Singh M, Kante B, Kumar P, Ranjan M, et al. Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis. Aliment Pharmacol Ther 2021. … (more)
- Is Part Of:
- Journal of Crohn's and colitis. Volume 16(2022)Supplement 1
- Journal:
- Journal of Crohn's and colitis
- Issue:
- Volume 16(2022)Supplement 1
- Issue Display:
- Volume 16, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 16
- Issue:
- 1
- Issue Sort Value:
- 2022-0016-0001-0000
- Page Start:
- i611
- Page End:
- i612
- Publication Date:
- 2022-01-21
- Subjects:
- Inflammatory bowel diseases -- Periodicals
616.344005 - Journal URLs:
- http://www.journals.elsevier.com/journal-of-crohns-and-colitis/ ↗
http://ecco-jcc.oxfordjournals.org/content/9/3 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1093/ecco-jcc/jjab232.837 ↗
- Languages:
- English
- ISSNs:
- 1873-9946
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4965.651500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21031.xml